Molecular subtypes of bladder cancer and therapeutic targets скачать в хорошем качестве

Molecular subtypes of bladder cancer and therapeutic targets

Vadim Koshkin, MD, University of California, San Francisco, CA, provides an overview of the molecular landscape of tumors and the classification of bladder cancer into subtypes, including luminal and basal subtypes, with further subcategories within these groups, as well as a neuroendocrine subtype. Certain subtypes, such as luminal, are more likely to express specific markers like nectin-4 and FGFR3 alterations, making them potential targets for existing therapies, while basal subtypes require additional treatment options. This interview took place at the 2026 ASCO GU Cancers Symposium in San Francisco, CA. These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.